Sign In
Buy SOPH
$5.67
-0.0900 (-1.56%)
At Close: Jul 31, 2026
SOPHiA GENETICS SA (SOPH) Q1 2024 Earnings Call Transcript
02:46am, Sunday, 12'th May 2024
SOPHiA GENETICS SA (NASDAQ:SOPH ) Q1 2024 Earnings Conference Call May 7, 2024 8:00 AM ET Company Participants Kellen Sanger - Head, Strategy and IR Jurgi Camblong - Co-Founder and CEO Ross Muken - CF
Wall Street Analysts Think SOPHiA GENETICS (SOPH) Could Surge 64.95%: Read This Before Placing a Bet
10:56am, Tuesday, 07'th May 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 65% in SOPHiA GENETICS (SOPH). While the effectiveness of this highly sought-after metric is questionable, the
SOPHiA GENETICS Reports First Quarter 2024 Results
06:45am, Tuesday, 07'th May 2024
Consistent Operational Execution; Robust New Business Momentum; Guidance Reaffirmed Consistent Operational Execution; Robust New Business Momentum; Guidance Reaffirmed
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference
07:05am, Tuesday, 30'th Apr 2024
BOSTON and ROLLE, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced that Chief Financial Officer an
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
10:29am, Tuesday, 23'rd Apr 2024
BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial r
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa
05:05am, Tuesday, 23'rd Apr 2024
Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout Africa BOSTON and ROLLE, Switzerland , April 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a c
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)
06:05am, Wednesday, 17'th Apr 2024
European-based Unilabs has deployed the SOPHiA DDM™ Platform across its network in Switzerland to support cancer diagnostics and treatment BOSTON and ROLLE, Switzerland , April 17, 2024 /PRNewswire
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership
01:00am, Thursday, 04'th Apr 2024
The companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland , April 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native
Laboratorio Barnafi-Krause is Live on SOPHiA DDM™
10:00am, Tuesday, 02'nd Apr 2024
The Chile-based Laboratory is using SOPHiA GENETICS' platform to advance its research capabilities with blood disorders BOSTON and ROLLE, Switzerland , April 2, 2024 /PRNewswire/ -- SOPHiA GENETICS (
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada
10:00am, Wednesday, 20'th Mar 2024
University of Saskatchewan's (USask) Advanced Diagnostics Research Laboratory will use SOPHiA DDM™ Platform to advance research on ovarian cancer care BOSTON and ROLLE, Switzerland , March 20, 202
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration
06:00am, Friday, 15'th Mar 2024
New Multimodal Algorithm Highlights Predictive Benefit Of Artificial Intelligence (AI) for Cancer Research BOSTON and ROLLE, Switzerland , March 15, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH)
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
12:07pm, Thursday, 07'th Mar 2024
BOSTON and ROLLE, Switzerland, March 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Chief Financial
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
06:45am, Tuesday, 05'th Mar 2024
Strong momentum to continue in 2024 as SOPHiA GENETICS announces record revenue, 35 new customer additions in Q4, and 36% cash burn decline in FY 2023 Strong momentum to continue in 2024 as SOPHiA GEN
SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference
08:45am, Thursday, 22'nd Feb 2024
BOSTON and ROLLE, Switzerland, Feb. 22, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Co-founder and Ch
SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024
10:46am, Tuesday, 20'th Feb 2024
BOSTON and ROLLE, Switzerland, Feb. 20, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release i
